SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $625,335 | -21.0% | 4,537 | -25.7% | 0.12% | -38.1% |
| Q4 2022 | $791,604 | +235.4% | 6,109 | +186.5% | 0.19% | +250.0% |
| Q3 2022 | $236,000 | +4.0% | 2,132 | -26.9% | 0.05% | -42.6% |
| Q2 2021 | $227,000 | -55.0% | 2,917 | -56.5% | 0.09% | -50.5% |
| Q3 2019 | $505,000 | +58.8% | 6,703 | +178.2% | 0.19% | -22.4% |
| Q2 2018 | $318,000 | -20.7% | 2,409 | -55.5% | 0.24% | -27.3% |
| Q1 2018 | $401,000 | – | 5,409 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |